Antibiotic reduces harmful effects of HIV

news-image

Common med provides a cheap and effective treatment in sub-Saharan Africa. ANDREW MASTERSON reports.

A clinical trial involving HIV-positive children in sub-Saharan Africa has revealed that a common antibiotic significantly improves health – despite widespread antibiotic resistance.

In a paper published in the journal Science Translational Medicine, researchers led by Claire Bourke from the Queen Mary University of London in the UK detail a trial involving 293 children in Zimbabwe and Uganda.

The children were all given the antibiotic cotrimoxazole for a minimum of 96 weeks.

The antibiotic has long been recognised for its prophylactic effect in people with HIV and AIDS, and is recommended by the World Health Organisation as “an affordable, safe and feasible intervention for resource-limited countries” dealing with HIV cases.

In the latest investigation to drill down into the effects of the medication, Bourke and colleagues studied plasma samples taken from the Ugandan and Zimbabwean cohort. After 96 weeks, treatment was halted for half of the children, and continued for the remainder.

The researchers found that those who continued treatment had lower rates of systemic inflammation and lower streptococcal bacterial activity than those who stopped. The latter group, also recorded an 18% higher risk of adverse health events, such as pneumonia, within 48 weeks of ceasing the antibiotics.

Cotrimoxazole was found to exert direct effects on the children’s immune cells. A small secondary trial found that the antibiotic also reduced inflammatory molecule production in HIV-positive adults.

Significantly, the antibiotic worked despite high levels of resistance found among the target population.

“Collectively, we demonstrate that cotrimoxazole reduces systemic and intestinal inflammation both indirectly via antibiotic effects on the microbiome and directly by blunting immune and epithelial cell activation,” Bourke and colleagues conclude.

“Synergy between these pathways may explain the clinical benefits of cotrimoxazole despite high antimicrobial resistance, providing further rationale for extending coverage among people living with HIV in sub-Saharan Africa.” ‑ Cosmos

LEAVE A COMMENT

Comments

image

Poachers have broken into Botswana’s p Read more...

10 Aug, 2018 at 01:58 PM

image

In a sign that Botswana is likely to cli Read more...

02 Jul, 2018 at 09:26 AM

image

DAR ES SALAAM - DIRECTIVES on online for Read more...

02 Jul, 2018 at 01:24 PM

image

Gaborone - Poachers have broken into Bot Read more...

04 Feb, 2019 at 07:35 AM

image

SADC leaders meeting in Tanzania this we Read more...

19 Aug, 2019 at 01:51 PM

image

Gaborone - A group of prominent former A Read more...

11 Oct, 2019 at 12:27 PM

image

The creation of a single liberalised mar Read more...

11 Oct, 2019 at 12:26 PM

image

Windhoek - Hot on the heels of the gradu Read more...

11 Oct, 2019 at 12:25 PM

image

African countries must up their game and Read more...

11 Oct, 2019 at 12:24 PM

image

Zimbabwe will lead the SADC Elections Ob Read more...

11 Oct, 2019 at 12:22 PM

image

Lusaka - Amid myriad criticisms from soc Read more...

14 Dec, 2018 at 06:28 AM

image

Windhoek - Tanzania has been outperformi Read more...

24 Sep, 2018 at 09:29 AM

image

Johannesburg - The year ahead will be ke Read more...

28 Jan, 2019 at 09:44 AM

image

Heads of state and ministers who travell Read more...

30 Jul, 2018 at 02:01 PM

image

Windhoek - The European Union National I Read more...

01 Apr, 2019 at 12:33 PM